ART3 Inhibitors

ART3 inhibitors as a chemical class would include substances that can mitigate the enzymatic function of ART3 through various indirect mechanisms. These mechanisms can involve competition with essential substrates, interference with cofactor availability, modulation of related enzymes within the ADP-ribosylation process, or perturbation of cellular signaling pathways that regulate ART3 activity. For instance, Nicotinamide competes with NAD+, a substrate necessary for the ADP-ribosylation that ART3 catalyzes, thereby reducing ART3's ability to modify its protein substrates. Methanocarbathymidine and 3-Aminobenzamide are inhibitors of PARPs; their action can lead to altered levels of ADP-ribosylation within the cell, which may in turn influence ART3 activity, given the shared reliance on similar substrates and possibly overlapping substrates or regulatory mechanisms.

Further, compounds like PJ-34 and 5-Iodotubercidin are capable of indirectly affecting ART3 by modulating the metabolism of poly(ADP-ribose) or adenosine kinases, respectively. This modulation can lead to changes in the cellular pools of ADP-ribose, which is necessary for ART3's enzymatic activity. Theophylline, by inhibiting phosphodiesterases, and Tiopronin, through its redox-modulating properties, can also impact the signaling pathways that regulate ART3 or the redox environment necessary for its optimal function. Isoniazid may influence ART3 by reducing the availability of NAD+, thus affecting the substrate pool ART3 requires for activity. Similarly, 6-Aminonicotinamide acts as a metabolic inhibitor that can lead to changes in NAD+ metabolism, potentially reducing ART3 activity.